(Food and Drug Administration, FDA)--
The FDA has approved the first generic nasal spray used to reverse opioid overdoses.
Generic Naloxone has been available for years in an *injectable* form in a health care setting, but this is the first generic nasal spray that anyone can use without training.
It can be used on both adults and children by spraying it into one nostril while the person is lying on his or her back. The FDA says the spray can be repeated if necessary.
According to the CDC, more than 130 americans die every day from overdoses involving opioid drugs.
- FDA approves first generic nasal spray to reverse overdoses
- FDA approves first postpartum depression drug
- Locals react to approval of generic EpiPen
- Combating fentanyl overdoses
- Flu shot may be more effective than nasal vaccine, study says
- Working Families Party reverses course, backs Cuomo
- FDA has 5 weeks until money runs out for approving new drugs
- Demi Lovato hospitalized for apparent drug overdose
- Drug overdose deaths skyrocketed among women
- Police confirm possible overdose death in Utica